DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer

NCT06757244 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Neoplasms

Interventions

DRUG: Dostarlimab
DRUG: Vitamin D3 (Cholecalciferol)
DRUG: mFOLFIRINOX Treatment Regimen
DRUG: LV5FU2

Sponsor

Hopital Foch

Collaborators

[object Object]